Investing in Teva- Pharmaceutical Industries Ltd. ADR (TEVA): What You Must Know

Roman Campbell

Teva- Pharmaceutical Industries Ltd. ADR’s filing revealed that its Shareholder Bridger Management, LLC (1) acquired Company’s shares for reported $1.25 million on Nov 26 ’25. In the deal valued at $24.99 per share,50,000 shares were bought.

Then, Fox Christine sold 28,229 shares, generating $699,523 in total proceeds. Upon selling the shares at $24.78, the EVP, Head of U.S. Commercial now owns 63,647 shares.

Before that, Fox Christine bought 28,229 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $699,523 were divested by the Officer at a price of $24.78 per share.

Goldman initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy in a research note published on June 06, 2025; the price target was $24. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. JP Morgan also remained covering TEVA and has increased its forecast on May 12, 2025 with a “an Overweight” recommendation from previously “Neutral” rating. Argus revised its rating on July 10, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.

Price Performance Review of TEVA

On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock jump 2.17% to $26.89. Over the last five days, the stock has gained 10.75%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 61.11% since the year began. Nevertheless, the stocks have risen 22.01% over the past one year. While a 52-week high of $26.44 was reached on 11/28/25, a 52-week low of $12.47 was recorded on 04/10/25.

Levels Of Support And Resistance For TEVA Stock

The 24-hour chart illustrates a support level at 26.53, which if violated will result in even more drops to 26.18. On the upside, there is a resistance level at 27.10. A further resistance level may holdings at 27.32.

How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?

A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-11-14, dropping by -0.84 million shares to a total of 46.44 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-15 was 47.28 million shares. There was a decline of -1.81%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.